JPH0143741B2 - - Google Patents
Info
- Publication number
- JPH0143741B2 JPH0143741B2 JP15141981A JP15141981A JPH0143741B2 JP H0143741 B2 JPH0143741 B2 JP H0143741B2 JP 15141981 A JP15141981 A JP 15141981A JP 15141981 A JP15141981 A JP 15141981A JP H0143741 B2 JPH0143741 B2 JP H0143741B2
- Authority
- JP
- Japan
- Prior art keywords
- optically active
- acid
- phthalimide
- reaction
- tryptophan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical class C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 12
- -1 4-substituted phenylhydrazine Chemical class 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- JMKLVQRQCLMCIN-VIFPVBQESA-N (2s)-5-amino-2-(1,3-dioxoisoindol-2-yl)-5-oxopentanoic acid Chemical compound C1=CC=C2C(=O)N([C@@H](CCC(=O)N)C(O)=O)C(=O)C2=C1 JMKLVQRQCLMCIN-VIFPVBQESA-N 0.000 claims description 5
- 238000007363 ring formation reaction Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 claims description 4
- 229940067157 phenylhydrazine Drugs 0.000 claims description 4
- 125000001041 indolyl group Chemical group 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000013078 crystal Substances 0.000 description 16
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000007810 chemical reaction solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HPTXLHAHLXOAKV-INIZCTEOSA-N (2S)-2-(1,3-dioxo-2-isoindolyl)-3-(1H-indol-3-yl)propanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1[C@H](C(=O)O)CC1=CNC2=CC=CC=C12 HPTXLHAHLXOAKV-INIZCTEOSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- OTRSODUBJNLGQS-JTQLQIEISA-N (2s)-2-(1,3-dioxoisoindol-2-yl)-5-oxopentanoic acid Chemical compound C1=CC=C2C(=O)N([C@@H](CCC=O)C(=O)O)C(=O)C2=C1 OTRSODUBJNLGQS-JTQLQIEISA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 2
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 2
- JOVOSQBPPZZESK-UHFFFAOYSA-N phenylhydrazine hydrochloride Chemical compound Cl.NNC1=CC=CC=C1 JOVOSQBPPZZESK-UHFFFAOYSA-N 0.000 description 2
- 229940038531 phenylhydrazine hydrochloride Drugs 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YSBHDZULGNBTHX-UHFFFAOYSA-N 1,4-dioxan-2-yl acetate Chemical compound CC(=O)OC1COCCO1 YSBHDZULGNBTHX-UHFFFAOYSA-N 0.000 description 1
- SBNOTUDDIXOFSN-UHFFFAOYSA-N 1h-indole-2-carbaldehyde Chemical compound C1=CC=C2NC(C=O)=CC2=C1 SBNOTUDDIXOFSN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VBKPPDYGFUZOAJ-UHFFFAOYSA-N 5-oxopentanoic acid Chemical compound OC(=O)CCCC=O VBKPPDYGFUZOAJ-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- OCDGBSUVYYVKQZ-UHFFFAOYSA-N gramine Chemical compound C1=CC=C2C(CN(C)C)=CNC2=C1 OCDGBSUVYYVKQZ-UHFFFAOYSA-N 0.000 description 1
- GOERTRUXQHDLHC-UHFFFAOYSA-N gramine Natural products COC1=CC=C2NC=C(CN(C)C)C2=C1 GOERTRUXQHDLHC-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- OVNUPJXMCMTQCN-UHFFFAOYSA-N hydron;(4-phenylmethoxyphenyl)hydrazine;chloride Chemical compound Cl.C1=CC(NN)=CC=C1OCC1=CC=CC=C1 OVNUPJXMCMTQCN-UHFFFAOYSA-N 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000004031 phenylhydrazines Chemical class 0.000 description 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Description
本発明は光学活性N−フタリルグルタミンより
光学活性なトリプトフアン誘導体に効率よく導く
新規な製造法である。
光学活性N−フタリルトリプトフアン及びその
5−ベンジルオキシ誘導体は、医薬品等として重
要な光学活性トリプトフアン及び5−ヒドロキシ
トリプトフアンの合成中間体として有用な化合物
であり、常法で保護法を除去することにより光学
活性トリプトフアン及び光学活性5−ヒドロキシ
トリプトフアンにすることが出来る。
従来、光学活性トリプトフアン類を化学的に合
成する公知の方法は、インドールアルデヒド、グ
ラミンなどのインドール核を持つ原料から出発す
る方法と、合成途中でインドール環を形成する方
法に大別することが出来る。しかしこれら従来の
方法は最終的にはラセミトリプトフアン誘導体を
合成し物理化学的、化学的或いは酵素的に光学分
割を行い、所望の光学活性体を得るものであり、
これと対掌の光学活性体はラセミ化して回収し、
分割操作を繰返す等の極めて煩雑な操作が必要で
あり、収率低下の大きな要因ともなつており、何
れも工業的に有利な方法とは言い難い。
そこで、本発明者らは工業的に有利な光学活性
トリプトフアン誘導体の化学的合成法について鋭
意研究を行ない、先に特許出願(特開昭55−
69565)したが、更に研究を行なつた結果、光学
活性N−フタリルグルタミンを原料とし、これに
脱水反応を行なつて新規物質である光学活性α−
フタルイミド−γ−シアノ酪酸とし、これを還元
して光学活性α−フタルイミド−γ−ホルミル酪
酸とした後、フエニルヒドラジン又は4−置換フ
エニルヒドラジンと反応させ、インドール閉環反
応を行うことにより、光学活性N−フタリル−ト
リプトフアン誘導体がラセミ化することなく得ら
れることを見出し、工業的に有利な光学活性トリ
プトフアン誘導体の製造法を完成した。本発明法
は、1)アミノ保護基がフタリル基である為にエ
ステル化という工程を加えなくてもラセミ化する
ことなくトリプトフアン誘導体に導くことが出来
る。2)中間体の有機溶媒への溶解性が大きいた
め取扱いが容易である。3)得られたフタリルト
リプトフアン誘導体はヒドラジン処理などの比較
的温和な処理によつて、有用なトリプトフアン誘
導体が得られる。
本発明を化学式で示せば次のとおりである。
本発明に於て、原料として使用する光学活性N
−フタリルグルタミンは工業的に安価に製造され
ている光学活性グルタミン酸或いは光学活性グル
タミンから公知の方法で容易に製造される化合物
である。
本発明の第1工程は光学活性N−フタリルグル
タミン(I)を光学活性α−フタルイミド−γ−
シアノ酪酸()とすることにある。(I)を
()とする反応は一般的な脱水剤を作用させる
ことにより得られるが、例えば無水酢酸を用いる
場合よく粉砕した(I)を無水酢酸中に加え、少
時加温することによつて容易にニトリル体()
とすることが出来る。使用する無水酢酸は反応溶
媒を兼ねており、2〜10倍モル、好ましくは5倍
モル程度である。反応温度は溶媒の沸点以下任意
の温度で実施可能であるが、反応性等を考慮し
100℃前後が適当である。この様な条件下では30
分から1時間で脱水反応は完結する。尚、ニトリ
ル体()は新規な化合物であり結晶として単離
することが出来る。一般的には反応物を単離精製
後次工程の反応に使用されるが、単離操作を省略
し反応液をそのまま次の反応に使用することも可
能である。結晶単離方法としては反応液を減圧下
に濃縮して無水酢酸を留去し、酢酸エチル等の溶
媒を加えて溶解後、ジシクロヘキシルアミン(以
下DCHAと略す)を加え、冷却するとDCHA塩
が結晶として析出する。メタノールから再結晶す
ると光学活性N−フタルイミド−γ−シアノ酪酸
DCHA塩の白色結晶、融点;176.0〜177.5℃、L
体の比旋光度〔α〕20 D−23.8゜(C=5、MeOH)を
得る。
このDCHA塩をイオン交換樹脂等を用いて脱
アミンし、得られる結晶を水から再結晶すること
により、光学活性α−フタルイミド−γ−シアノ
酪酸()、融点;115.0〜126.0℃、L体の比旋
光度〔α〕20 D−61.5゜(C=1、MeOH)の白色結晶
を得る。
本発明の第2工程は第1工程で得られたニトリ
ル体()を還元してアルデヒド体()とする
ことにある。即ち、ニトリル体()を酢酸等の
有機溶媒または水性溶媒に溶解し、ラネーニツケ
ル触媒を用いて場合によつては鉛又は鉛イオンの
共存下に接触還元すると、目的とする光学活性な
アルデヒド体()を得る。反応溶媒としては蟻
酸、酢酸、酪酸等の有機酸及びその水性溶媒、更
に必要があればアルコール、ジオキサン、テトラ
ヒドロフラン等の水溶性有機溶媒を添加使用する
ことが出来る。ラネーニツケル触媒の使用量はニ
トリル体()に対して10〜30重量%程度が適当
である。還元温度、還元水素圧は特に制限はない
が、常温、常圧が好ましい。後処理方法としては
還元終了後、触媒を去し、液をクロロホル
ム、酢酸エチル等の適当な有機溶媒で抽出し、有
機溶媒層を乾燥後、溶媒を留去することによつて
アルデヒド体()を結晶として得る。これを酢
酸から再結晶すると新規な化合物である光学活性
α−フタルイミド−γ−ホルミル酪酸()の白
色結晶、融点;129.0〜132.0℃、L体の比旋光度
〔α〕20 D−32.0゜(C=1、MeOH)を得る。尚、ア
ルデヒド体()は結晶として単離し、次の反応
に用いてもよいが、単離することなく反応液をそ
のまま次の反応に使用することも十分可能であ
り、また操作の上からもこちらが有利である。ま
た、アルデヒド体()の2,4−ジニトロフエ
ニルヒドラゾン、フエニルヒドラゾンも結晶とし
て単離することが出来、これらヒドラゾン類はい
ずれも新規化合物であり、その構造式、物性は次
のとおりである。
The present invention is a novel production method that more efficiently leads to optically active tryptophan derivatives than optically active N-phthalylglutamine. Optically active N-phthalyltryptophan and its 5-benzyloxy derivative are compounds useful as intermediates for the synthesis of optically active tryptophan and 5-hydroxytryptophan, which are important as pharmaceuticals. By doing so, optically active tryptophan and optically active 5-hydroxytryptophan can be obtained. Conventionally known methods for chemically synthesizing optically active tryptophans can be roughly divided into methods that start from raw materials with an indole nucleus such as indole aldehyde and gramine, and methods that form an indole ring during synthesis. . However, these conventional methods ultimately synthesize a racemic tryptophan derivative and perform optical resolution physicochemically, chemically, or enzymatically to obtain the desired optically active substance.
This and the opposite optically active form were racemized and recovered.
This method requires extremely complicated operations such as repeated splitting operations, which is a major factor in reducing the yield, and it is difficult to say that either method is industrially advantageous. Therefore, the present inventors conducted intensive research on an industrially advantageous chemical synthesis method for optically active tryptophan derivatives, and filed a patent application (Japanese Patent Application Laid-Open No.
However, as a result of further research, optically active N-phthalylglutamine was used as a raw material, and a new substance, optically active α-
Phthalimide-γ-cyanobutyric acid is reduced to optically active α-phthalimide-γ-formylbutyric acid, and then reacted with phenylhydrazine or 4-substituted phenylhydrazine to perform an indole ring-closing reaction. It was discovered that active N-phthalyl-tryptophan derivatives can be obtained without racemization, and an industrially advantageous method for producing optically active tryptophan derivatives was completed. In the method of the present invention, 1) since the amino protecting group is a phthalyl group, a tryptophan derivative can be obtained without racemization without adding an esterification step. 2) Handling is easy because the intermediate has high solubility in organic solvents. 3) A useful tryptophan derivative can be obtained by subjecting the obtained phthalyltryptophan derivative to a relatively mild treatment such as hydrazine treatment. The chemical formula of the present invention is as follows. In the present invention, optically active N used as a raw material
-Phthalylglutamine is a compound that can be easily produced by a known method from optically active glutamic acid or optically active glutamine, which is industrially produced at low cost. The first step of the present invention is to convert optically active N-phthalylglutamine (I) into optically active α-phthalimide-γ-
Cyanobutyric acid (). The reaction of (I) to () can be obtained by using a general dehydrating agent, but for example, when using acetic anhydride, it is necessary to add well-pulverized (I) to acetic anhydride and heat it for a short time. Therefore, it is easily converted into nitrile ()
It can be done. The acetic anhydride used also serves as a reaction solvent, and is about 2 to 10 times the molar amount, preferably about 5 times the molar amount. The reaction temperature can be any temperature below the boiling point of the solvent, but
Appropriate temperature is around 100℃. Under these conditions 30
The dehydration reaction is completed in minutes to one hour. Note that the nitrile compound () is a new compound and can be isolated as a crystal. Generally, the reaction product is isolated and purified before being used in the next reaction step, but it is also possible to omit the isolation operation and use the reaction solution as it is in the next reaction. The crystal isolation method is to concentrate the reaction solution under reduced pressure, distill off acetic anhydride, add a solvent such as ethyl acetate to dissolve it, add dicyclohexylamine (hereinafter abbreviated as DCHA), and cool it to crystallize the DCHA salt. It precipitates as Optically active N-phthalimide-γ-cyanobutyric acid when recrystallized from methanol
White crystals of DCHA salt, melting point: 176.0-177.5℃, L
Obtain the specific optical rotation [α] 20 D -23.8° (C=5, MeOH). This DCHA salt is deamined using an ion exchange resin, etc., and the resulting crystals are recrystallized from water to obtain optically active α-phthalimide-γ-cyanobutyric acid (), melting point: 115.0-126.0°C, L-form. A white crystal with a specific optical rotation [α] 20 D -61.5° (C=1, MeOH) is obtained. The second step of the present invention is to reduce the nitrile () obtained in the first step to form an aldehyde (). That is, by dissolving the nitrile compound () in an organic solvent such as acetic acid or an aqueous solvent and subjecting it to catalytic reduction using a Raney-nickel catalyst in the presence of lead or lead ions, the desired optically active aldehyde compound ( ). As the reaction solvent, organic acids such as formic acid, acetic acid, and butyric acid and their aqueous solvents can be used, and if necessary, water-soluble organic solvents such as alcohol, dioxane, and tetrahydrofuran can be added. The appropriate amount of Raney nickel catalyst to be used is about 10 to 30% by weight based on the nitrile (). Although there are no particular restrictions on the reduction temperature and reduction hydrogen pressure, normal temperature and normal pressure are preferable. As a post-treatment method, after the completion of the reduction, the catalyst is removed, the liquid is extracted with an appropriate organic solvent such as chloroform or ethyl acetate, the organic solvent layer is dried, and the solvent is distilled off to obtain the aldehyde (). obtained as crystals. When this was recrystallized from acetic acid, a new compound, optically active α-phthalimide-γ-formylbutyric acid (), was obtained as white crystals, melting point: 129.0-132.0°C, specific optical rotation of L-form [α] 20 D -32.0° ( C=1, MeOH) is obtained. The aldehyde compound () may be isolated as a crystal and used in the next reaction, but it is also possible to use the reaction solution as it is in the next reaction without isolation, and from an operational standpoint. This is advantageous. In addition, the aldehyde (2,4-dinitrophenylhydrazone) and phenylhydrazone can also be isolated as crystals, and these hydrazones are all new compounds, and their structural formulas and physical properties are as follows. be.
【式】 融点;62〜71℃(分解) L体の比旋光度〔α〕20 D−45.8゜(C=1、CHCl3)[Formula] Melting point: 62-71℃ (decomposed) Specific rotation of L-form [α] 20 D -45.8゜ (C=1, CHCl 3 )
【式】
融点;164.0〜167.0゜
L体の比旋光度〔α〕20 D−49.2゜(C=2、DMF)
本発明の第3工程はアルデヒド体()にフエ
ニルヒドラゾン又はその4置換体を反応させ、イ
ンドール閉環反応を行い、光学活性トリプトフア
ン誘導体()とすることにある。第2工程で得
られたアルデヒド体()の結晶又は反応液にフ
エニルヒドラジン又はその4置換体を加え、これ
に酸触媒として塩酸、硫酸、p−トルエンスルホ
ン酸、強酸性イオン交換樹脂等の強酸を加え加熱
することにより、インドール閉環反応が起こり、
目的とする光学活性トリプトフアン誘導体が得ら
れる。尚、ヒドラジン類は遊離型は勿論のこと、
鉱酸塩の形で同様に使用することが出来る。フエ
ニルヒドラジン類の添加量は当モル以上であれば
よいが1.0〜1.5倍モル程度が好ましい。
強酸の添加量は反応溶液の酸濃度が0.5規定以
下、好ましくは0.1規定程度になる量を添加し、
また反応溶媒は水又はアルコール、酢酸ジオキサ
ン、テトラヒドラフラン等の水溶性溶媒及びこれ
らの混合溶媒等が使用出来る。反応温度は反応溶
媒の沸点以下任意の温度で実施可能であるが60〜
100℃程度が望ましい。尚、この反応工程を2段
階に分け、まずアルデヒド体()とフエニルヒ
ドラジン類との反応を完結させ、フエニルヒドラ
ゾン誘導体として単離した後、次のインドール閉
環反応を行なつて目的とする光学活性トリプトフ
アン誘導体()とすることも可能である。
このようにして得られた反応生成物を酢酸エチ
ル、クロロホルム等の有機溶媒で抽出し、有機溶
媒層を乾燥後、適当な処理を施すことにより目的
とする光学活性N−フタリルトリプトフアン誘導
体がよい収率で得られる。
尚、本発明法においては、L−N−フタルイグ
ルタミンを原料として用いればすべてがL−N−
フタリルトリプトフアン誘導体となり、又D−N
−フタリルグルタミンを原料として用いればすべ
てがD−N−フタリルトリプトフアン誘導体とな
る。
以上の如く、本発明法は安価にして入手容易な
光学活性グルタミン酸或いは光学活性グルタミン
から容易に得られる光学活性フタリルグルタミン
を原料として、合成化学的に光学活性トリプトフ
アン誘導体を製造する方法であり、従来の公知の
方法では必須と考えられていた光学分割を必要と
しない方法であり、トリプトフアン類の製造法と
しては新規にして有用な方法である。
次に本発明の実施例について説明する。
実施例 1
L−α−フタルイミド−γ−シアノ酪酸()
の合成
100℃に加温した無水酢酸50mlによく粉砕した
フタリル−L−グルタミン27.6g(0.1モル)の結
晶のまま加え、同温度で1時間撹拌後、減圧濃
縮。残渣にAcoEtを加えて溶解冷却すると結晶が
析出するので、これを去、液にジシクロヘキ
シルアミンを加え冷却すると、29.4gのL−α−
フタルイミド−γ−シアノ酪酸のジシクロヘキシ
ルアミン塩を得る。収率66.9%、MeOHから再結
晶すると、融点;176.0〜177.5℃、〔α〕20 D−23.8゜
(C=5、MeOH)の白色羽毛晶を得る。
元素分析値(%) C H N
計算値 68.31 7.57 9.56
分析値 68.31 7.45 9.60
L−α−フタルイミド−γ−シアノ酪酸ジシク
ロヘキシルアミン塩29.4を75%MeOH300mlに溶
解し、1R120H型樹脂を加えて1時間放置。樹脂
を去後、濃縮乾固すると17.3gのL−α−フタ
ルイミド−γ−シアノ酪酸を得る。収率66.9%、
水から再結晶すると、融点;115〜126.0℃、〔α〕
20 D−61.5゜(C=1、MeOH)の白色結晶を得る。
元素分析値(%) C H N
計算値 60.47 3.90 10.85
分析値 60.19 4.17 10.69
実施例 2
(i) L−α−フタルイミド−γ−ホルミル酪酸
()の合成
L−α−フタルイミド−γ−シアノ酪酸
25.8g(0.1モル)を25%AcOH500mlに溶解し、
3%鉛で被毒したラネーニツケル6gを添加し、
室温、常圧下で接触還元。水素ガス2.4を吸
収したところ還元をやめ、触媒を去。液を
CHCl3で抽出。CHCl3層をMgSO4乾燥後
CHCl3を留去すると、21.8gのL−α−フタル
イミド−γ−ホルミル酪酸を含む酢酸溶液を得
る。収率83.5%エーテル−n−ヘキサンを加え
ると結晶化する。酢酸から再結晶すると融点;
129.0〜132.0℃、〔α〕20 D−32.0゜(C=1、
MeOH)の白色結晶を得る。
元素分析値(%) C H N
計算値 59.77 3.86 5.36
分析値 59.59 4.32 5.40
(ii) 2,4−ジニトロフエニルヒドラゾンの単離
L−α−フタルイミド−γ−シアノ酪酸
2.58g(0.01モル)、25%酢酸50ml、3%鉛被毒
ラネーニツケル0.6gで(i)と同様の操作で還元を
行ない、触媒を去した液を2,4−ジニト
ロフエニルヒドラジン1.98gを含む2N塩酸400
mlに加えると3.71gのL−α−フタルイミド−
γ−ホルミル酪酸−2,4−ジニトロフエニル
ヒドラゾンを得る。収率84.1%、メタノール−
水から再結晶すると融点;164.0〜167.0℃、
α〕20 D−49.2゜(C=2、DMF)の黄色結晶を得
る。
元素分析値(%) C H N
計算値 51.71 3.43 15.87
分析値 51.51 3.50 15.71
(iii) フエニルヒドラゾンの単離
L−α−フタルイミド−γ−シアノ酪酸
2.58g(0.01モル)25%酢酸50ml3%鉛被毒ラネ
ーニツケル0.6gを用いて(i)と同様の操作で還元
を行ない、触媒を去した液をフエニルヒド
ラジン塩酸塩1.45gを含む水溶液15mlに加え、
CHCl3で抽出。CHCl3層をMgSO4乾燥後濃縮
乾固すると、2.40gのL−α−フタルイミド−
γ−ホルミル酪酸フエニルヒドラゾンを非結晶
性粉末として得る。収率68.3%、融点;62〜71
℃(分解)、〔α〕20 D−45.8゜(C=1、CHCl3)
元素分析値(%) C H N
計算値 64.95 4.88 11.96
分析値 64.10 4.77 12.03
実施例 3
N−フタリル−L−トリプトフアンの合成
(i) L−α−フタルイミド−γ−ホルミル酪酸か
らの合成
フエニルヒドラジン塩酸塩1.74g(0.012モル)
を含む0.2N塩酸メタノール50mlに実施例2で
得たL−α−フタルイミド−γ−ホルミル酪酸
2.61g(0.01モル)を含む酢酸溶液を加え、1時
間加熱還流する。後、メタノールを留去し、酢
酸エチルで抽出。酢酸エチル層をMgSO4乾燥
後濃縮。残渣をベンゼン:メタノール=9:1
を溶媒として、シリカゲルを用いたカラムクロ
マトグラフイーにかけ、目的物の留出部分を濃
縮乾固すると、2.50gのN−フタリル−L−ト
リプトフアンを得る。収率48.5%、融点;65〜
70℃、〔α〕20 D−263.0゜(C=1、MeOH)
元素分析値(%) C H N
計算値 68.26 4.22 8.38
分析値 67.88 4.01 8.27
(ii) フエニルヒドラゾンからの合成
実施例2で得たL−α−フタルイミド−γ−
ホルミル酪酸フエニルヒドラゾン3.51g(0.01モ
ル)を0.1塩酸100ml中で1時間加熱還流する。
反応液を酢酸エチルで抽出。その後(i)と同様の
処理を行ない、2.34gのN−フタリル−L−ト
リプトフアンを得る。収率70.1%。
実施例 4
5−ベンジルオキシ−N−フタリル−L−トリ
プトフアンの合成
4−ベンジルオキシフエニルヒドラジン塩酸塩
3.01g(0.012モル)を含むメタノール100mlに実施
例2で得たL−α−フタルイミド−γ−ホルミル
酪酸2.61g(0.01モル)を含む酢酸溶液を加え3時
間加熱還流する。反応液を濃縮乾固後酢酸エチル
溶液とし不溶物を去、酢酸エチル層を濃縮乾
固。残渣をベンゼン:メタノール=9:1を溶媒
として、シリカゲルを用いたカラムクロマトグラ
フイーにかけ、目的物の留出部分を濃縮乾固する
と2.48gの5−ベンジルオキシ−N−フタリル−
L−トリプトフアンを得る。収率56.3%、融点;
72〜76℃、〔α〕20 D−187.0゜(C=1、MeOH)
元素分析値(%) C H N
計算値 70.90 4.58 6.36
分析値 70.28 4.55 6.25[Formula] Melting point: 164.0-167.0゜Specific optical rotation of L form [α] 20 D -49.2゜ (C=2, DMF) The third step of the present invention is to add phenylhydrazone or its 4-substituted product to the aldehyde (). The purpose is to react the indole ring-closing reaction to obtain an optically active tryptophan derivative (). Phenylhydrazine or its 4-substituted product is added to the crystals of the aldehyde () obtained in the second step or the reaction solution, and an acid catalyst such as hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, or a strongly acidic ion exchange resin is added to this. By adding a strong acid and heating, an indole ring closure reaction occurs,
The desired optically active tryptophan derivative is obtained. In addition, hydrazines are not only in free form, but also in
It can likewise be used in the form of mineral salts. The amount of phenylhydrazine added may be at least the equivalent molar amount, but is preferably about 1.0 to 1.5 times the molar amount. The amount of strong acid added is such that the acid concentration of the reaction solution is 0.5N or less, preferably about 0.1N,
As the reaction solvent, water, water-soluble solvents such as alcohol, dioxane acetate, and tetrahydrofuran, and mixed solvents thereof can be used. The reaction temperature can be carried out at any temperature below the boiling point of the reaction solvent, but from 60 to
Approximately 100℃ is desirable. This reaction process is divided into two steps. First, the reaction between the aldehyde () and the phenylhydrazines is completed, and the phenylhydrazone derivative is isolated. After that, the next indole ring-closing reaction is carried out to obtain the desired product. It is also possible to use an optically active tryptophan derivative (). The reaction product thus obtained is extracted with an organic solvent such as ethyl acetate or chloroform, and after drying the organic solvent layer, the desired optically active N-phthalyltryptophan derivative is obtained by subjecting it to an appropriate treatment. Obtained in good yield. In addition, in the method of the present invention, if L-N-phthaliglutamine is used as a raw material, all L-N-
It becomes a phthalyltryptophan derivative, and also D-N
-If phthalylglutamine is used as a raw material, all of the products will be DN-phthalyltryptophan derivatives. As described above, the method of the present invention is a method for synthetically producing an optically active tryptophan derivative using optically active glutamic acid or optically active phthalylglutamine, which is easily obtained from optically active glutamine, as a raw material, and which is inexpensive and easily available. This method does not require optical resolution, which was considered essential in conventional known methods, and is a new and useful method for producing tryptophans. Next, examples of the present invention will be described. Example 1 L-α-phthalimide-γ-cyanobutyric acid ()
Synthesis of 27.6 g (0.1 mol) of well-pulverized phthalyl-L-glutamine was added as crystals to 50 ml of acetic anhydride heated to 100°C, stirred at the same temperature for 1 hour, and concentrated under reduced pressure. When AcoEt was added to the residue and the solution was cooled, crystals were precipitated, so this was removed, and dicyclohexylamine was added to the solution and cooled, resulting in 29.4 g of L-α-
A dicyclohexylamine salt of phthalimido-γ-cyanobutyric acid is obtained. Recrystallization from MeOH gives white feather crystals with a yield of 66.9% and a melting point of 176.0-177.5°C, [α] 20 D -23.8° (C=5, MeOH). Elemental analysis value (%) C H N Calculated value 68.31 7.57 9.56 Analysis value 68.31 7.45 9.60 L-α-phthalimide-γ-cyanobutyric acid dicyclohexylamine salt 29.4 was dissolved in 300 ml of 75% MeOH, 1R120H type resin was added and left for 1 hour. . After removing the resin, the residue was concentrated to dryness to obtain 17.3 g of L-α-phthalimido-γ-cyanobutyric acid. Yield 66.9%,
When recrystallized from water, melting point: 115-126.0℃, [α]
20 D -61.5° (C=1, MeOH) white crystals are obtained. Elemental analysis value (%) C H N Calculated value 60.47 3.90 10.85 Analysis value 60.19 4.17 10.69 Example 2 (i) Synthesis of L-α-phthalimide-γ-formylbutyric acid () L-α-phthalimide-γ-cyanobutyric acid
Dissolve 25.8g (0.1mol) in 500ml of 25% AcOH,
Added 6g of Raney Nickel poisoned with 3% lead,
Catalytic reduction at room temperature and normal pressure. After absorbing 2.4% of hydrogen gas, reduction stopped and the catalyst left. liquid
Extracted with CHCl3 . After drying 3 layers of CHCl and 4 MgSO
After distilling off CHCl 3 , an acetic acid solution containing 21.8 g of L-α-phthalimido-γ-formylbutyric acid is obtained. Yield: 83.5% Ether-n-hexane is added to crystallize. Melting point when recrystallized from acetic acid;
129.0~132.0℃, [α] 20 D -32.0゜(C=1,
Obtain white crystals of MeOH). Elemental analysis value (%) C H N Calculated value 59.77 3.86 5.36 Analytical value 59.59 4.32 5.40 (ii) Isolation of 2,4-dinitrophenylhydrazone L-α-phthalimide-γ-cyanobutyric acid
Reduction was carried out in the same manner as in (i) using 2.58 g (0.01 mol), 50 ml of 25% acetic acid, and 0.6 g of 3% lead-poisoned Raney nickel. Contains 2N hydrochloric acid 400
3.71g of L-α-phthalimide when added to ml
γ-formylbutyric acid-2,4-dinitrophenylhydrazone is obtained. Yield 84.1%, methanol-
Melting point when recrystallized from water: 164.0-167.0℃;
α] 20 D -49.2° (C=2, DMF) yellow crystals are obtained. Elemental analysis value (%) C H N Calculated value 51.71 3.43 15.87 Analytical value 51.51 3.50 15.71 (iii) Isolation of phenylhydrazone L-α-phthalimide-γ-cyanobutyric acid
2.58 g (0.01 mol) 50 ml of 25% acetic acid 0.6 g of 3% lead-poisoned Raney nickel was used for reduction in the same manner as in (i), and the catalyst-removed solution was dissolved in 15 ml of an aqueous solution containing 1.45 g of phenylhydrazine hydrochloride. In addition,
Extracted with CHCl3 . After drying the CHCl 3 layer with MgSO 4 and concentrating to dryness, 2.40 g of L-α-phthalimide
Phenylhydrazone γ-formylbutyrate is obtained as an amorphous powder. Yield 68.3%, melting point: 62-71
°C (decomposition), [α] 20 D -45.8° (C = 1, CHCl 3 ) Elemental analysis value (%) C H N Calculated value 64.95 4.88 11.96 Analysis value 64.10 4.77 12.03 Example 3 N-phthalyl-L-tryptophan Synthesis (i) Synthesis from L-α-phthalimide-γ-formylbutyric acid Phenylhydrazine hydrochloride 1.74g (0.012 mol)
L-α-phthalimide-γ-formylbutyric acid obtained in Example 2 in 50 ml of 0.2N hydrochloric acid methanol containing
Add an acetic acid solution containing 2.61 g (0.01 mol) and heat under reflux for 1 hour. After that, methanol was distilled off and extracted with ethyl acetate. The ethyl acetate layer was dried with MgSO4 and then concentrated. Benzene:methanol=9:1
The mixture was subjected to column chromatography using silica gel as a solvent, and the distilled portion of the target product was concentrated to dryness to obtain 2.50 g of N-phthalyl-L-tryptophan. Yield 48.5%, melting point: 65~
70℃, [α] 20 D −263.0° (C=1, MeOH) Elemental analysis value (%) C H N Calculated value 68.26 4.22 8.38 Analysis value 67.88 4.01 8.27 (ii) Synthesis from phenylhydrazone In Example 2 Obtained L-α-phthalimide-γ-
3.51 g (0.01 mol) of phenylhydrazone formylbutyrate is heated under reflux for 1 hour in 100 ml of 0.1 hydrochloric acid.
Extract the reaction solution with ethyl acetate. Thereafter, the same treatment as in (i) is carried out to obtain 2.34 g of N-phthalyl-L-tryptophan. Yield 70.1%. Example 4 Synthesis of 5-benzyloxy-N-phthalyl-L-tryptophan 4-benzyloxyphenylhydrazine hydrochloride
An acetic acid solution containing 2.61 g (0.01 mol) of L-α-phthalimido-γ-formylbutyric acid obtained in Example 2 was added to 100 ml of methanol containing 3.01 g (0.012 mol), and the mixture was heated under reflux for 3 hours. The reaction solution was concentrated to dryness, made into an ethyl acetate solution, the insoluble matter was removed, and the ethyl acetate layer was concentrated to dryness. The residue was subjected to column chromatography using silica gel using benzene:methanol=9:1 as a solvent, and the distilled portion of the target product was concentrated to dryness to give 2.48 g of 5-benzyloxy-N-phthalyl-
Obtain L-tryptophan. Yield 56.3%, melting point;
72-76℃, [α] 20 D -187.0゜ (C=1, MeOH) Elemental analysis value (%) C H N Calculated value 70.90 4.58 6.36 Analysis value 70.28 4.55 6.25
Claims (1)
し、これに脱水反応を行なつて、光学活性α−フ
タルイミド−γ−シアノ酪酸とし、ついで還元し
て光学活性α−フタルイミド−γ−ホルミル酪酸
とし、更にフエニルヒドラジン又は4置換フエニ
ルヒドラジンと反応させてインドール閉環反応を
行うことを特徴とする光学活性トリプトフアン誘
導体の製造法。1 Using optically active N-phthalylglutamine as a raw material, it is subjected to a dehydration reaction to form optically active α-phthalimide-γ-cyanobutyric acid, and then reduced to optically active α-phthalimide-γ-formylbutyric acid, and further 1. A method for producing an optically active tryptophan derivative, which comprises reacting with phenylhydrazine or 4-substituted phenylhydrazine to perform an indole ring closure reaction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15141981A JPS5855459A (en) | 1981-09-26 | 1981-09-26 | Preparation of optically active tryptophan derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15141981A JPS5855459A (en) | 1981-09-26 | 1981-09-26 | Preparation of optically active tryptophan derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5855459A JPS5855459A (en) | 1983-04-01 |
| JPH0143741B2 true JPH0143741B2 (en) | 1989-09-22 |
Family
ID=15518199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15141981A Granted JPS5855459A (en) | 1981-09-26 | 1981-09-26 | Preparation of optically active tryptophan derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5855459A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342146A (en) * | 1999-03-18 | 2002-03-27 | 塞尔基因公司 | Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing the content of inflammatory cytokines |
| WO2007007054A1 (en) * | 2005-07-08 | 2007-01-18 | Cancer Research Technology Limited | Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| CN102175400B (en) * | 2011-02-21 | 2013-05-29 | 深圳市易特照明有限公司 | Device for detecting product waterproof property |
-
1981
- 1981-09-26 JP JP15141981A patent/JPS5855459A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5855459A (en) | 1983-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5210215A (en) | Tryptophane and 3-indolepyruvic acid, methods of production therefor | |
| JP2997979B2 (en) | Method for producing 5-aminolevulinic acid | |
| MacPhillamy et al. | The Alkaloids of Tabernanthe iboga. Part VI. 1 The Synthesis of the Selenium Dehydrogenation Products from Ibogamine | |
| NO162587B (en) | DEVICE FOR AA MONITORING THE PRESENCE OF A PERSON IN A BED. | |
| JP2846042B2 (en) | Method for producing indolecarboxylic acid derivative | |
| JPH0143741B2 (en) | ||
| US4614806A (en) | Process for the asymmetric synthesis of chiral indoline-2-carboxylic acids | |
| Wuonola et al. | Imidazole alkaloids of Macrorungia longistrobus: revised structures and total syntheses | |
| Rinderknecht et al. | Oxindolylalanine | |
| Feuer et al. | The Chemistry of Cyclic Hydrazides. 1 VIII. The Preparation of Substituted N-Aminomaleimides and Their Conversion to N-Substituted Maleic Hydrazides2 | |
| US3092660A (en) | 1-acyl-2-alkyl-hydrazine derivatives | |
| CA1098910A (en) | 3-amino-2-(5-fluoro and 5-methoxy-1h-indol-3-yl) propanoic acid derivatives | |
| JPS59204172A (en) | Preparation of acemetacin | |
| Holland et al. | 57. New syntheses of DL-tryptophan. Part I. Syntheses from ethyl α-aceto-β-3-indolylpropionate and ethyl α-cyano-β-3-indolylpropionate | |
| JP2945957B2 (en) | Method for producing fluorine-containing primary amine | |
| JP3256208B2 (en) | Method for producing 2-oxindole | |
| BE828003A (en) | NEW DERIVATIVES OF AROMATIC AMIDOCARBOXYLIC ACIDS | |
| JPS60204750A (en) | Method for preparing DL-β-arylamino acids | |
| JPS6388184A (en) | Production of alpha-n-((hypoxanthin-9-yl)- pentyloxycarbonyl)-alginine | |
| US4727183A (en) | Process for the asymmetric synthesis of chiral α-hydroxy-2-nitrobenzenepropanoic acid | |
| US4644081A (en) | Process for the asymmetric synthesis of chiral indoline-2-carboxylic acids | |
| Masuzawa et al. | The reaction of C-substituted ethylenediamine with the ester of α-halo acid | |
| JP2767295B2 (en) | Method for producing indole-3-carbonitrile compound | |
| JP2892526B2 (en) | Method for producing ketones having substituted amino group | |
| US3697508A (en) | Process for preparing benzodiazocines and benzodiazonines |